- Trials with a EudraCT protocol (89)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
89 result(s) found for: structured clinical interview for DSM-IV.
Displaying page 1 of 5.
EudraCT Number: 2009-010625-39 | Sponsor Protocol Number: MZ09-PCP-SosPeter | Start Date*: 2010-04-21 |
Sponsor Name:Prague Psychiatric Center | ||
Full Title: QEEG cordance and EEG connectivity changes after administration of subanesthetic ketamine doses in depressive disorder patients | ||
Medical condition: INCLUSION CRITERIA: 1. Men and women at the age between 18 to 65 years, with dextromanual dominance. 2. Patients have to answer DSM IV criteria for the major depressive episode, without psychotic s... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002456-90 | Sponsor Protocol Number: 14060802 | Start Date*: 2015-02-13 |
Sponsor Name:Stockholm Centre for Dependency Disorders, Department of Clinical Neuroscience, Karolinska Institutet | ||
Full Title: Integrated Exposure-Based Therapy for Co-occurring Posttraumatic Stress Disorder and Alcohol Dependence: Effects of the FAAH inhibitor PF-04457845 on Extinction. A Randomized Controlled Trial. | ||
Medical condition: Current Posttraumatic Stress Disorder (PTSD) and Current Alcohol Dependence | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-007538-21 | Sponsor Protocol Number: CYR-101C01 | Start Date*: 2008-04-22 | |||||||||||
Sponsor Name:CYRENAIC | |||||||||||||
Full Title: A Multi-center, Inpatient and ambulatory, Phase 2, Double-blind, Randomised, Placebo-controlled Proof of Concept Study of CYR-101 in Patients with DSM-IV Schizophrenia | |||||||||||||
Medical condition: Diagnosis of Schizophrenia in Male or female patients, as defined in Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revised (DSM-IV TR, APA 2000) and confirmed by the St... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004681-33 | Sponsor Protocol Number: D1447C00001 | Start Date*: 2005-04-15 |
Sponsor Name:AstraZeneca AB | ||
Full Title: An International, Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel™, single oral 300 mg or 600... | ||
Medical condition: Bipolar Depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: LT (Completed) LV (Completed) EE (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012428-10 | Sponsor Protocol Number: MBCT2009 | Start Date*: 2009-11-06 |
Sponsor Name:University of Exeter | ||
Full Title: Preventing depression relapse / recurrence in NHS settings through mindfulness-based cognitive therapy (MBCT). | ||
Medical condition: Recurrent depression. Patients who have experienced 3 or more episodes of depression and are already taking anti-depressants will be invited to take part in this study. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2010-023446-70 | Sponsor Protocol Number: | Start Date*: 2011-07-22 |
Sponsor Name:Med. Univ. Wien, Univ. Klinik für Psychiatrie und Psychotherapie | ||
Full Title: Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response | ||
Medical condition: Major Depressive Disorder (MDD) remains to be under-recognized and under-treated, though it is amongst the leading causes of disease burden worldwide. Despite the proven efficacy of modern antidepr... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-000160-28 | Sponsor Protocol Number: MusicPlasticity | Start Date*: 2020-08-28 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Investigation of SSRI induced neuroplastic changes in musicians using functional magnetic resonance imaging | ||
Medical condition: Focal dystonia in musicians | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001573-28 | Sponsor Protocol Number: Uni-Koeln-320 | Start Date*: 2007-11-26 |
Sponsor Name:Universität zu Köln | ||
Full Title: Prevent: Secondary Prevention of Schizophrenia. A randomized controlled trial. | ||
Medical condition: Persons at risk of being prodromally symptomatic of psychosis (PAR) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021044-17 | Sponsor Protocol Number: CLOCK_depression | Start Date*: 2010-08-11 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: The effect of agomelatine on CLOCK gene expression in patients with major depressive disorder and healthy controls: an exploratory study. | |||||||||||||
Medical condition: Major depressive disorder (MDD), Seasonal affective disorder (subtype of MDD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023007-10 | Sponsor Protocol Number: TF2010 | Start Date*: 2011-03-22 | |||||||||||
Sponsor Name:Uppsala university | |||||||||||||
Full Title: A neuroscience perspective on anxiety proneness - Sex differences, monoaminergic pathways and treatment response | |||||||||||||
Medical condition: Men and women diagnosed with DSM-IV social phobia (social anxiety disorder) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003191-39 | Sponsor Protocol Number: | Start Date*: 2013-01-21 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: The effect of a single-dose of d-cycloserine on the basic effects of cognitive-behaviour therapy for panic disorder - a randomized placebo-controlled trial | |||||||||||||
Medical condition: DSM-IV Panic disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004909-16 | Sponsor Protocol Number: D1447C00134 | Start Date*: 2005-05-03 |
Sponsor Name:AstraZeneca AB | ||
Full Title: An International, Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel™, single oral 300 mg or 600... | ||
Medical condition: Depressive episodes in bipolar disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018405-12 | Sponsor Protocol Number: RGH-MD-11 | Start Date*: 2010-10-11 | |||||||||||
Sponsor Name:Forest Research Institute, Inc. | |||||||||||||
Full Title: Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients with Schizophrenia | |||||||||||||
Medical condition: Schizophrenia is a lifelong disabling psychiatric disorder with a reported worldwide prevalence of about 1%. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004860-31 | Sponsor Protocol Number: 2.2.20110919 | Start Date*: 2011-10-27 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders | ||
Medical condition: Major Depressive Disorder Anxiety Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-000955-40 | Sponsor Protocol Number: CI-1008-152 | Start Date*: 2004-09-23 |
Sponsor Name:Pfizer Global Research & Development | ||
Full Title: A Placebo-Controlled Study of Pregabalin in Elderly Patients With Generalized Anxiety Disorder | ||
Medical condition: Generalized Anxiety Disorder | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005001-78 | Sponsor Protocol Number: KLI148-B00 | Start Date*: 2012-01-26 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Psychiatrie u. Psychotherapie, Abteil. für biologische Psychiatrie | ||
Full Title: Neural Correlates of SSRI Drug Response: Impact of Stress System Genes | ||
Medical condition: Major Depressive Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002068-14 | Sponsor Protocol Number: KET_po | Start Date*: 2017-01-03 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Investigation of antidepressant efficacy of oral ketamine treatment | ||
Medical condition: Major depressive episode (Major depressive disorder, Biploar disorder) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005019-16 | Sponsor Protocol Number: ROCKSAN | Start Date*: 2009-03-19 |
Sponsor Name:AMC- academisch psychiatrisch centrum | ||
Full Title: Randomized Olanzapine Clozapine Key study on Schizophrenia and Addiction in the Netherlands (ROCKSAN) | ||
Medical condition: A multi-centre prospective, randomized, double blind designed study examining the effectiveness and costs of clozapine compared to olanzapine in patients with schizophrenia or related psychotic dis... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004018-33 | Sponsor Protocol Number: PrefrontalCircuits | Start Date*: 2020-08-24 |
Sponsor Name:Department of Psychiatry and Psychotherapy, Medical University of Vienna | ||
Full Title: Prefrontal circuits for cognitive flexibility in an extradimensional set-shifting task for humans. | ||
Medical condition: Major depressive disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003623-23 | Sponsor Protocol Number: can.clo.ris.fMRI | Start Date*: 2008-09-17 |
Sponsor Name:Academisch medisch centrum, department of psychiatry | ||
Full Title: Effect of different antipsychotic medication on craving related brain activity in patients with schizophrenia and cannabis abuse or dependence: a randomized controlled study comparing clozapine and... | ||
Medical condition: A randomized controlled trial comparing the effect of clozapine and risperidone on cannabis craving in cannabis abusing or dependent patients with schizophrenia. Specific cognitive tasks will be us... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
